Complejo Hospitalario Universitario Insular Materno Infantil

At Complejo Hospitalario Universitario Insular Materno Infantil in Las Palmas De Gran Canaria, the oncology research portfolio is focused on neoplasms, with studies centered on advanced solid tumors and targeted cancer care. The trials are exploring whether new treatments can improve treatment effectiveness, tumor control, and overall clinical outcomes for patients with difficult-to-treat cancers.

• Advanced RET-altered malignancies
• Locally advanced/metastatic urothelial cancer
• Evaluating a new therapy for cancer and its impact on response and disease control

This research reflects a strong interest in precision oncology, including studies designed to better understand how targeted and combination approaches may help patients whose cancers have limited standard options.

The site is also studying targeted therapy approaches for cancers with specific genetic changes, especially tumors with RET alterations. These trials aim to assess both safety and effectiveness of investigational treatment options in patients with genetically defined disease.

• RET-altered tumours
• RET fusion-positive non-small cell lung cancer
• Testing a new targeted treatment for cancers driven by abnormal RET signaling

Research in this area is focused on improving outcomes for patients with molecularly selected cancers, including people who have already received earlier targeted treatment and those starting therapy for the first time.